Details of the Drug

General Information of Drug (ID: DMXQSWW)

Drug Name

Autologous anti-gp100 T-cell receptor gene-engineered peripheral blood lymphocytes

Synonyms

Autologous anti-gp100 T-cell receptor gene-engineered peripheral blood lymphocytes (melanoma); Autologous anti-gp100 TCR gene-engineered PBLs (melanoma), NCI; Autologous anti-gp100 T-cell receptor gene-engineered peripheral blood lymphocytes (melanoma), National Cancer Institute

Indication

Disease Entry	ICD 11	Status	REF
Melanoma	2C30	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

TTD ID: D0I3VS

References

1	ClinicalTrials.gov (NCT00509496) Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Anti-gp100:154-162 TCR Gene Engineered Lymphocytes. U.S. National Institutes of Health.